Antiangial drug classes Flashcards
What is the prototype organic nitrate
nitroglycerin
MOA of nitroglycerin
prodrug metabolized to NO in VSM by ALDH2, relaxes VSM and dilates blood vessels reducing preload
efficacy of nitroglycerin
increases exercise tolerance and reduces symptoms, but produces no survival benefit
Cardiovascular effects of nitroglycerin
no inotropic or chronotropic effects at usual doses, at higher doses reflex tachycardia due to decreased MAP
Pharmacogenetics of nitroglycerine
ALDH2 polymorphism (30-50% in asians) reduces clinical efficacy
Pharmacokinetics of nitroglycerin
Oral or cutaneous preps for slow onset, long duration, but most common are sublingual NTG, fast acting short duration
Adverse effects of nitroglycerin
headaches, orthostatic hypotension, reflex tachycardia
Drug interactions of nitroglycerin
vasodilator drugs for ED (blood pressure)
alcohol (ALDH2)
Two classes of CCBs
Dihydropyridines and heart rate-lowering
Prototype dihydropyridines
nifedipine
Heart-rate lowering prototypes
verapamil, diltiazem
MOA of CCBs
block voltage gated L-type calcum channels by binding alpha-1 subunit. increase vasodilation decrease afterload
Efficacy of CCBs
prophylaxis for angina attacks, no survival benefit
Features of Nifedipine
greater inhibitory action on VSM than myocardium, little effect on SA and AV nodes
Features of Verapamil and diltiazem
Also act on SA and AV nodal tissue decreasing heart rate and contractility , less potent vasodilators
Difference between verapamil and diltiazem
diltiazem produces less cardiac depression and is better tolerated
Adverse effects of verapamil
dradyarrhythmias, cardiac depression, constipation
Adverse effects of diltiazem
bradyarrhythmias, cardiac depression
Adverse effects of nifedipine
reflex tahycardia, flushing, peripheral edema
Beta blocker for angina
propranalol
MOA of propranalol for angina
decreases heart rate, contractile force and systemic blood pressure.
Efficacy of propranalol
reduces severity and frequence of angina attacks, reduces mortality, not effective for vasospastic angina.
Therapeutic approach to angina
beta blockers w/ nitroglycerin as needed, CCBs second line as monotherapy.
Prototype PDE5 Inhibitor
sildenafil (viagra)
MOA of sildenafil
inhibits PDE-5 (isoform in VSM of corpora cavernosum) prevents cGMP degredation, allows dilation and erection.
Pharmacokinetics of sildenafil
1 hr before anticipated sexual activity 2-4 hr duration, decreased by high fat diet. Metabolized by CYP3A4
Adverse effects of sildenafil
hedache flushing, nasal congestion, dyspepsia, abnormal vision, hearing loss, priapism
Drug interactions with sildenafil
can potentiate the effects of organic nitrates and alpha blockers